Published Date: 02 Mar 2023
Over a long lunch of meat and rice, Asim al-Shammari recently turned to the sight of bites from restaurants he himself said were affected by Saudi anti-corruption laws.
Read Full NewsAn investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.
A biological computer using human neurons learns Doom within 1 week, highlighting rapid adaptive learning and potential advantages over traditional AI systems.
The findings could fill a treatment gap for patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC) who also carry TP53 mutations.
Both drugs increase overall and progression-free survival.
1.
Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.
2.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
3.
a brand-new generic therapy for different types of cancer.
4.
Novel Drugs Boost Immunotherapy Activity in Resectable Lung Cancer
5.
Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?
1.
Unpacking the Importance of White Blood Cells (WBCs) in the Body
2.
Unleashing the Oncolytic Arsenal: Talimogene Laherparepvec Monotherapy – A Targeted Cancer Immunotherapy Treatment
3.
Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma
4.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
5.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part I
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
5.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation